Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2021 Filed Apr 8, 2021 22:02 UTC |
Machado FernandoChief Marketing Officer
|
GrantRestricted Share Units · Derivative | 49.2205 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026137 · doc4.xml · derivative · entry 6 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,130.2787 Underlying: Common Shares · 49.2205 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:02 UTC |
Machado FernandoChief Marketing Officer
|
GrantPerformance Share Units · Derivative | 1,632.5702 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026137 · doc4.xml · derivative · entry 5 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,331.996 Underlying: Common Shares · 1,632.5702 shares Expires 2024-02-22 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:02 UTC |
Machado FernandoChief Marketing Officer
|
GrantRestricted Share Units · Derivative | 35.5796 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026137 · doc4.xml · derivative · entry 4 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,431.3398 Underlying: Common Shares · 35.5796 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:02 UTC |
Machado FernandoChief Marketing Officer
|
GrantRestricted Share Units · Derivative | 45.3309 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026137 · doc4.xml · derivative · entry 2 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,645.8401 Underlying: Common Shares · 45.3309 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F3 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantPerformance Share Units · Derivative | 162.6909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 16 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,262.6909 Underlying: Common Shares · 162.6909 shares Expires 2024-02-19 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common share underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 57.8564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 15 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,205.8564 Underlying: Common Shares · 57.8564 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 80.1313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 14 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,980.1313 Underlying: Common Shares · 80.1313 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantPerformance Share Units · Derivative | 211.0057 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 13 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,280.164 Underlying: Common Shares · 211.0057 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common share underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 28.376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 12 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,534.1565 Underlying: Common Shares · 28.376 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 40.3188 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 10 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021.5882 Underlying: Common Shares · 40.3188 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 8.702 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 8 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083.8123 Underlying: Common Shares · 8.702 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantPerformance Share Units · Derivative | 724.8081 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 7 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,272.7968 Underlying: Common Shares · 724.8081 shares Expires 2023-02-23 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2018 PBRSUs") granted to the Reporting Person. The 2018 PBRSUs had a three-year performance period beginning January 1, 2015 and ending December 31, 2018 and will vest on February 23, 2023, which is the fifth anniversary of the grant date. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common share underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:03 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 10.7217 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026138 · doc4.xml · derivative · entry 5 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,335.356 Underlying: Common Shares · 10.7217 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 162.6909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,262.6909 Underlying: Common Shares · 162.6909 shares Expires 2024-02-19 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 84.9149 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 17 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575.9149 Underlying: Common Shares · 84.9149 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 80.1313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,980.1313 Underlying: Common Shares · 80.1313 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 211.0057 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 15 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,280.164 Underlying: Common Shares · 211.0057 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 63.0569 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 14 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,853.5642 Underlying: Common Shares · 63.0569 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 434.6568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 12 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,135.2765 Underlying: Common Shares · 434.6568 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 74.3437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,259.2977 Underlying: Common Shares · 74.3437 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 87.4508 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,891.7549 Underlying: Common Shares · 87.4508 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:00 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 106.3174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026134 · doc4.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241.5262 Underlying: Common Shares · 106.3174 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 813.4545 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 21 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,313.4545 Underlying: Common Shares · 813.4545 shares Expires 2024-02-19 F21 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F14 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 225.5333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 20 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,089.5333 Underlying: Common Shares · 225.5333 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F20 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F20 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 400.6567 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 19 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,900.6567 Underlying: Common Shares · 400.6567 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F19 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F19 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,110.0571 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 18 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,801.6398 Underlying: Common Shares · 2,110.0571 shares Expires 2025-02-21 F18 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F14 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 145.0031 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 17 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,059.7287 Underlying: Common Shares · 145.0031 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F17 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F17 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,390.6125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 16 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,744.0207 Underlying: Common Shares · 2,390.6125 shares Expires 2024-02-22 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F14 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 124.8595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 15 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,550.8995 Underlying: Common Shares · 124.8595 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F15 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,993.2223 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 14 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,250.1913 Underlying: Common Shares · 1,993.2223 shares Expires 2023-02-23 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2018 PBRSUs") granted to the Reporting Person. The 2018 PBRSUs had a three-year performance period beginning January 1, 2015 and ending December 31, 2018 and will vest 100% on February 23, 2023, which is the fifth anniversary of the grant date. F14 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 142.5876 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 13 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,758.879 Underlying: Common Shares · 142.5876 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F12 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:59 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 151.6846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026133 · doc4.xml · derivative · entry 12 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,891.8929 Underlying: Common Shares · 151.6846 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F11 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 37.6455 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 14 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,688.6455 Underlying: Common Shares · 37.6455 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 121.4111 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,121.4111 Underlying: Common Shares · 121.4111 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 84.4023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 12 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512.0656 Underlying: Common Shares · 84.4023 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 30.8406 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 11 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,841.1088 Underlying: Common Shares · 30.8406 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 173.8627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 10 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,654.1106 Underlying: Common Shares · 173.8627 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 38.3715 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,779.0622 Underlying: Common Shares · 38.3715 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 31.3273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,901.7243 Underlying: Common Shares · 31.3273 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:01 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 43.6137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026135 · doc4.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,431.9568 Underlying: Common Shares · 43.6137 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantPerformance Share Units · Derivative | 677.8787 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 14 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,427.8787 Underlying: Common Shares · 677.8787 shares Expires 2024-02-19 F15 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 158.571 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 13 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,749.571 Underlying: Common Shares · 158.571 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 333.8806 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 12 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,583.8806 Underlying: Common Shares · 333.8806 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantPerformance Share Units · Derivative | 1,688.0457 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 11 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,241.3119 Underlying: Common Shares · 1,688.0457 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 122.0035 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,195.1908 Underlying: Common Shares · 122.0035 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantPerformance Share Units · Derivative | 1,955.9557 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,608.7442 Underlying: Common Shares · 1,955.9557 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 115.7317 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,414.0587 Underlying: Common Shares · 115.7317 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 153.5055 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,118.6724 Underlying: Common Shares · 153.5055 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:55 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 182.7594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026127 · doc4.xml · derivative · entry 5 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,762.1621 Underlying: Common Shares · 182.7594 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 22:04 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 216.9212 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026139 · doc4.xml · derivative · entry 14 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,016.9212 Underlying: Common Shares · 216.9212 shares Expires 2024-02-19 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F10 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.